Skip to main content

Table 1 Follow-up and duration of treatment (over 48 months from treatment initiation)

From: Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma

 

NIVO (n = 170)

NIVO + IPI (n = 177)

IPI (n = 167)

Follow-up (months)

 Mean

28.8

30.0

21.7

 Median

35.6

32.2

15.0

Duration of treatment (months)a

 Mean

14.2

10.8

1.8

 Median

5.5

2.5

2.1

  1. NIVO + IPI nivolumab + ipilimumab cohort, NIVO nivolumab monotherapy cohort, IPI ipilimumab monotherapy cohort
  2. aDuration of treatment has been taken to be the period from treatment start to last day of use of a drug
Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us